Your browser doesn't support javascript.
loading
Cell-bound complement activation products associate with lupus severity in SLE.
Arriens, Cristina; Alexander, Roberta Vezza; Narain, Sonali; Saxena, Amit; Collins, Christopher E; Wallace, Daniel J; Massarotti, Elena; Conklin, John; Kalunian, Kenneth C; Putterman, Chaim; Ramsey-Goldman, Rosalind; Buyon, Jill P; Askanase, Anca; Furie, Richard A; James, Judith A; Bello, Ghalib A; Manzi, Susan; Ahearn, Joseph; O'Malley, Tyler; Weinstein, Arthur; Dervieux, Thierry.
Afiliação
  • Arriens C; Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Alexander RV; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Narain S; Exagen Inc, Vista, California, USA ralexander@exagen.com.
  • Saxena A; Rheumatology, Northwell Health, Great Neck, New York, USA.
  • Collins CE; Center for Musculoskeletal Care, New York University, New York, New York, USA.
  • Wallace DJ; MedStar Washington Hospital Center, Washington, District of Columbia, USA.
  • Massarotti E; Attune Health, Beverly Hills, California, USA.
  • Conklin J; Rheumatology, Harvard University, Boston, Massachusetts, USA.
  • Kalunian KC; Exagen Inc, Vista, California, USA.
  • Putterman C; Rheumatology, University iof California San Diego, La Jolla, California, USA.
  • Ramsey-Goldman R; Division of Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Buyon JP; Azrieli Faculty of Medicine, Bar Ilan University, Zefat, Israel.
  • Askanase A; Research Institute, Galilee Medical Center, Nahariya, Israel.
  • Furie RA; Medicine/Rheumatology, Northwestern University, Chicago, Illinois, USA.
  • James JA; New York University School of Medicine, New York, New York, USA.
  • Bello GA; Rheumatology, Columbia University Medical Center, New York, New York, USA.
  • Manzi S; Rheumatology, Northwell Health, Great Neck, New York, USA.
  • Ahearn J; Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • O'Malley T; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Weinstein A; Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Dervieux T; Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Lupus Sci Med ; 7(1)2020 04.
Article em En | MEDLINE | ID: mdl-32371480
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C3 / Complemento C4 / Ativação do Complemento / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lupus Sci Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C3 / Complemento C4 / Ativação do Complemento / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lupus Sci Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos